Deep Apple Therapeutics
New York, US · Founded 2021
Founders & leadership
PD
Paul Da Silva JardineNamed on SEC filing
ME
Michael EhlersNamed on SEC filing
SL
Spiros LirasNamed on SEC filing
SH
Seth HarrisonNamed on SEC filing
BS
Brian ShoichetNamed on SEC filing
Reported raises · per SEC filings
Form D private placements▶$5MraisedDec 2021 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedDec 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul Da Silva JardineDirector
- Michael EhlersDirector
- Spiros LirasExecutive Officer, Director
- Seth HarrisonDirector
- Brian ShoichetDirector
- Offering amount
- $52M
- Amount sold
- $5M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Where is Deep Apple Therapeutics headquartered?
- Deep Apple Therapeutics is headquartered in New York, US.